Large-Scale Sequence Analysis of Hemagglutinin of Influenza A Virus Identifies Conserved Regions Suitable for Targeting an Anti-Viral Response by Sahini, Leepakshi et al.
Large-Scale Sequence Analysis of Hemagglutinin of
Influenza A Virus Identifies Conserved Regions Suitable
for Targeting an Anti-Viral Response
Leepakshi Sahini
1, Anna Tempczyk-Russell
2, Ritu Agarwal
1*
1Department of Process and Analytical Biochemistry, ChimericBio Incorporated, Long Island City, New York, United States of America, 2Department of Computational
Biology and Chemistry, Accelrys Incorporated, San Diego, California, United States of America
Abstract
Background: Influenza A viral surface protein, hemagglutinin, is the major target of neutralizing antibody response and
hence a main constituent of all vaccine formulations. But due to its marked evolutionary variability, vaccines have to be
reformulated so as to include the hemagglutinin protein from the emerging new viral strain. With the constant fear of a
pandemic, there is critical need for the development of anti-viral strategies that can provide wider protection against any
Influenza A pathogen. An anti-viral approach that is directed against the conserved regions of the hemaggutinin protein has
a potential to protect against any current and new Influenza A virus and provide a solution to this ever-present threat to
public health.
Methodology/Principal Findings: Influenza A human hemagglutinin protein sequences available in the NCBI database,
corresponding to H1, H2, H3 and H5 subtypes, were used to identify highly invariable regions of the protein. Nine such
regions were identified and analyzed for structural properties like surface exposure, hydrophilicity and residue type to
evaluate their suitability for targeting an anti-peptide antibody/anti-viral response.
Conclusion/Significance: This study has identified nine conserved regions in the hemagglutinin protein, five of which have
the structural characteristics suitable for an anti-viral/anti-peptide response. This is a critical step in the design of efficient
anti-peptide antibodies as novel anti-viral agents against any Influenza A pathogen. In addition, these anti-peptide
antibodies will provide broadly cross-reactive immunological reagents and aid the rapid development of vaccines against
new and emerging Influenza A strains.
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Introduction
The recent outbreak of swine-origin influenza A (H1N1) that
began in April 2009 in Mexico has caused an immediate
international concern. In June 2009, the virus had already spread
to 70 countries and a global pandemic was declared by WHO [1].
Since then the virus has continued to spread to 168 countries and
has infected approx. 209,438 people worldwide [1]. Over the past
decade, influenza epidemics have been mild; nevertheless, influenza
A virus has been predicted as a major and unpredictable threat to
public health due to historic precedents [2,3]. Prior to the outbreak
of H1N1, H5N1 influenza virus infection in humans in South Asia
had caused a significant number of cases of severe disease and
deaths in humans and had led to a global concern about the
potential of this virus to evolve to pandemic proportions [4]. These
current and recurring events of Influenza A fatalities around the
world highlight this ever-present threat to global public health.
The inability to provide lasting protection to humans against
influenza A virus is due, in part, to the rapid evolution of the viral
surface glycoprotein, hemagglutinin (HA), which leads to a change
in its antigenic structure. Hemagglutinin plays a major role in
determining host specificity since it is responsible for viral binding
to host cell receptors and penetration of host membranes [5,6,7].
Influenza A hemagglutinin exists as 16 related subtypes in birds
[8,9]. Three subtypes, H1, H2 and H3, are found in viruses known
to have caused human pandemics and several subtypes are known
to infect other mammals, e.g. pigs and horses. During repeated
rounds of infection, selection, and re-infection, influenza viruses
undergo host-specific adaptations. The regions involved in host-
virus interactions including the receptor-binding site are likely to
resist changes, but the antigenic sites are subject to drift due to
immune surveillance. In addition, some regions may evolve for
other reasons e.g. to facilitate post-translational modification or to
facilitate protein folding and maintenance of secondary/tertiary
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hemagglutinin protein that are phylogenetically information rich,
would be good candidates for involvement in virus-host interac-
tions and for additional viral functions. This would be especially
true for regions shared by more than one subtype. In this work, we
attempt to identify such information-rich regions on the HA1
subunit of the HA protein, where the majority of the amino-acid
variation is located. This subunit is also highly exposed and, hence,
a target of neutralizing antibody responses [10]. Currently, it is not
possible to modulate the B-cell response to specific protein regions,
and hence, the current vaccines, which are composed mainly of
HA protein or inactivated virus, have to be reformulated as the
virus mutates and changes. Due to constant evolution of influenza
A viruses, there is an urgent need for the development of new
vaccine strategies and anti-viral therapies based on conserved
regions, which can provide wider protection against any new
Influenza A virus.
This study focuses on analysis of Influenza A human HA1
protein sequences available in the NCBI database, corresponding
to H1, H2, H3 and H5 subtypes. These sequences were used to
identify nine regions that were conserved across subtypes. These
conserved sites were further analyzed in terms of secondary
structure, hydrophilicity and solvent-accessible surface to deter-
mine their suitability for targeting anti-peptide antibodies/anti-
viral therapies.
This work will be critical in the development of new anti-viral
therapies such as peptide antibodies or a peptide vaccine that will
be effective against all current and possibly future Influenza A
strains. Further, due to evolutionary variability of the HA protein,
development of vaccines against emerging strains is delayed by
the non-availability of reagents/antibodies that recognize the new
viral strain. This type of information will also be useful in
designing broadly cross-reactive, immunological reagents/peptide
antibodies to quantify the new vaccine product until viral-specific
reagents become available.
Methods
Analysis of HA Sequences
All full length HA sequences were downloaded from NCBI Flu
database (as of July 2009). Separate files were generated for all H1,
H2, H3 and H5 sequences. Computing a simultaneous multiple
alignment across all subtypes for the HA segment is challenging for
several reasons including: 1) high sequence-variability between
subtypes, 2) large number of sequences that need to be aligned and
3) the need to correct for biased representation of the subtypes in
the sequence databases. As a surrogate, we aligned the sequences
in stages where we used a sensitive profile-profile alignment stage
to align sequences across subtypes. In order to achieve this, we first
aligned the HA sequences within each subtype using MUSCLE
3.6 [11] after filtering out frame-shifted and partial sequences
(based on an initial MUSCLE alignment and manual curation).
We also excluded subtypes that were poorly represented in the
NCBI database to eliminate any further bias in the results. The
profiles for each multiple-alignment were then aligned to the other
profiles using the profile-profile aligner COMPASS [12]. Because
the profile for H2 had the most significant alignments to the other
profiles, as measured by COMPASS E-values, it was used to create
a seeded multiple alignment for the profiles similar to a PSI-
BLAST [13] alignment. The profile multiple-alignment was then
expanded, based on the multiple-alignment for each profile, into a
multiple-alignment for all the sequences across subtypes. In the
final alignment, the sequence of 1HGJ (H3 HA structure) was
included to follow the H3 numbering.
Computing a conservation score for each column of the final
multiple-alignment was complicated by the uneven representation
of the subtypes in the alignment. Since weighted entropy scores
require ad-hoc weighting schemes for the various sequences in the
alignment, we instead relied on a simpler correlation-based score:
for each of the subtypes H1, H3 and H5, the dot product of the
profile column with the corresponding profile column of H2 was
used to estimate the correlation of the profiles. The correlation
with H2 was chosen because H2 was the seed profile for the multi-
alignment. The correlation values were rounded to two decimal
places and hence some correlation values were not exactly 1.0 but
very close to 1.0. The final conservation score was then taken to be
the minimum of these correlation scores, as a conservative
estimate of conservation. The above alignment results and their
correlation scores are shown in Table S1.
We concentrated on the HA1 subunit and manually identified
regions containing 6 residues or more, where more than 50%
residues had a final conservation score of 0.9–1.0, and selected
them as conserved regions. We chose a threshold of 6 residues as a
minimum length required for a peptide antibody response.
Analysis of HA Structure
All of the structure analysis was done using Accelrys software
discovery studio 2.0. The H3 structure (1HGJ) was downloaded
from the PDB site. A ribbon model of the HA monomer was
generated to depict the nine identified conserved regions. Each
region was enlarged to show the detailed three-dimensional (3-D)
structure of the above sites. The H1 structure (PDB: 1RVZ) was
used for comparison with the H3 structure.
The secondary structure was calculated using both DSSP
secondary structure prediction program [14] and from the PDB
file. Since the results of the two methods were similar, only the
results from DSSP program were tabulated. To calculate the
solvent accessible surface, each of the nine regions were selected
separately and calculations were performed by the method of
Connolly, using a probe radius of 1.40 Au [15,16]. Each of the
nine regions was also analyzed for the hydrophobicity value based
on Kyte and Doolittle [17]. The sum total of hydrophobicity value
of individual amino-acid residues was tabulated. A negative value
reflects low hydrophobicity or a hydrophilic nature for the region.
Results
Sequence Analysis
A comprehensive HA protein sequence analysis was performed
using sequences of H1, H2, H3 and H5 subtypes of Influenza A
that were available in the NCBI database, to identify all of the
invariable regions. The analysis was performed in two steps; first,
individual profiles of each subtype were generated and each profile
was then aligned to the H2 profile to obtain the most significant
alignments. The correlation plots of H2 with other subtypes reflect
that subtypes H2 and H5; and H2 and H1, were clearly more
similar than H2-H3 pair (Figure 1). The H2-H5 and H2-H1 pairs
had correlation scores ranging from 0.8–1.0 for 66% and 56% of
amino acid residues in HA1, respectively. However, a correlation
score of 0.8–1.0 was observed for only 33% of the residues in the
H2-H3 pair. Similar results have been reported previously by
Nobusawa et.al. [18], who showed that H1 subtype exhibited
58.7% and 55.7% identity of the HA1 subunit to the HA1’s in the
H2 and H5 subtypes respectively, and least identity to the H3
subtype (35.2%).
The sequence alignment data were distributed into two
components: residues with a conservation score of 0.9–1.0 were
considered as conserved residues and regions containing 6 residues
Hemagglutinin Conserved Region
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of 0.9–1.0 were grouped as conserved regions. Using these criteria,
we expected to miss out some important single amino-acid
positions and conformational epitopes but identify regions suitable
for anti-viral/peptide therapies. This data clearly identified the
nine most conserved regions within all subtypes as shown in
Table 1 and 2. The conservation score of each variable residue
within the identified conserved region was depicted within
brackets, if the variation resulted from similar residue that would
lead to no change in charge/hydrophobicity. The final conserva-
tion at each position in the selected conserved regions was higher
than it appears in Table 1 and 2, as the variation in the selected
regions, between subtypes often resulted in similar substitutions.
We concluded that, despite the large differences in the subtypes,
there were regions of low variability that could be prime targets for
anti-peptide/anti-viral responses.
Structure Analysis
Targeting of anti-viral agents/antibodies to specific regions of
the protein is complex and incompletely understood. Currently,
there is no effective method of predicting the epitope structure of
the pathogen and directing the antibody response to pre-defined
regions using protein as an antigen. However, there is evidence
that short peptides with pre-determined sequence specificity can
be used to raise anti-peptide antibodies, which recognize peptide-
specific region of the protein [19,20] and monoclonal antibodies
raised against synthetic peptides can cross-react with the intact
protein molecule [21]. A vast majority of the literature suggests
that not all regions of protein cross react with synthetic peptide
antibodies and a number of structural parameters like surface
exposure [22,23], hydrophilicity and residue type [17], influence
this propensity. Therefore, the above parameters were evaluated
at each of the nine identified sites to predict their accessibility to
anti-peptide antibodies.
The structure of HA of influenza A virus (subtype H3) strain
A/Aichi/2/68 was determined by Wilson et al., 1981 [24] and,
subsequently, studies of variant viruses enabled mapping of
antigenic sites on the protein (reviewed in ref. 10). More recently,
structures of the influenza A virus HA for three additional subtypes
were solved: H1 [25,26], H5 [27] and H9 [28]. We chose the H3
structure (PDB: 1HGJ) for our analysis to adhere to the numbering
used in sequence analysis.
The position of nine identified regions were mapped on the 3-D
structure of the HA monomer and shown in Figure 2A as a ribbon
model. Each identified region was also enlarged to depict the
details of the 3-D structure (Figure 2B). All of the identified sites
1–9 were colored in red (Figure 2B) and their secondary structure
details, hydrophobicity value and solvent-accessible surface area
were tabulated (Table 3). Site 1 was present at the N-terminus of
HA1. This site contains the conserved cysteine residue that forms a
Figure 1. Correlation plots of Influenza A subtypes. Correlation of H2-H5, H2-H3 and H2-H1 in HA1 domain are shown. H3 residue numbering
was followed in this analysis.
doi:10.1371/journal.pone.0009268.g001
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H2 H1 H3 H5
Column
Number
Consensus
Residue
Column
Number
Consensus
Residue
Column
Number
Consensus
Residue
Column
Number
Consensus
Residue
Residue
Numbering
from 1HGJ
Final
conservation
Score
SITE 1
31 (I) 32 (I) 39 (L) 29 (I) 13 (0)
32 C 33 C 40 C 30 C 14 1
33 (I) 34 (I) 41 (L) 31 (I) 15 (0)
34 G 35 G 42 G 32 G 16 1
35 Y 36 Y 43 H 33 Y 17 0
36 H 37 H 44 H 34 H 18 1
37 A 38 A 45 A 35 A 19 0.96
SITE 2
89 (L) 90 (I) 96 (L) 87 (L) 70 (0.02)
90 L 91 L 97 L 88 L 71 1
91 G 92 G 98 G 89 G 72 1
92 N 93 N 99 D 90 N 73 0
93 P 94 P 100 P 91 P 74 1
94 E 95 E 101 Q 92 M 75 0
95 C 96 C 102 C 93 C 76 1
96 (D) 97 (E) 103 (D) 94 (D) 77 (0.01)
SITE 3
118 C 119 C 123 C 116 C 97 1
119 Y 120 Y 124 Y 117 Y 98 1
120 P 121 P 125 P 118 P 99 1
121 G 122 G 126 Y 119 G 100 0
122 S 123 Y 127 D 120 S 101 0
123 (F) 124 (F) 128 (V) 121 (F) 102 (0)
124 N 125 A 129 P 122 N 103 0
125 D 126 D 130 D 123 D 104 0.99
126 Y 127 Y 131 Y 124 Y 105 1
127 E 128 E 132 A 125 E 106 0
128 E 129 E 133 S 126 E 107 0
129 L 130 L 134 L 127 L 108 1
130 (K) 131 (R) 135 (R) 128 (K) 109 (0)
SITE 4
200 L 203 L 203 L 199 L 177 1
201 I 204 V 204 Y 200 V 178 0
202 (I) 205 (L) 205 (I) 201 (L) 179 (0)
203 W 206 W 206 W 202 W 180 1
204 G 207 G 207 G 203 G 181 1
205 (V) 208 (V) 208 (V) 204 (I) 182 (0)
206 H 209 H 209 H 205 H 183 1
207 H 210 H 210 H 206 H 184 0.99
208 P 211 P 211 P 207 P 185 0.96
SITE 5
238 P 241 P 241 P 237 P 215 1
239 E 242 E 242 N 238 K 216 0.01
240 I 243 I 243 I 239 I 217 0.97
241 A 244 A 244 G 240 A 218 0
242 T 245 K 245 S 241 T 219 0
Hemagglutinin Conserved Region
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HA monomer with a large solvent-accessible surface area. Site 2
and site 7 had few residues that formed a part of known antibody
binding sites E and C respectively [10]. Site 2 was mostly a-helical
while site 7 had mostly a b-structure. Both these sites had small
solvent-accessible surface areas and may be inaccessible/buried in
the monomer.
Site 3 was composed of both, a a-helical region and a loop with
a large solvent-accessible surface area, similar to site 1. This region
was highly hydrophilic and has been shown to be immunodomi-
nant in eliciting antibodies against a synthetic peptide [29,30].
However, this region does not form a part of known antibody
binding site indicating that in solution, this region may acquire
some conformation that is accessible only to peptide antibodies.
Sites 4 and 6 were mainly present as a b-sheet and appeared to
be hidden in the monomer. Site 8 and site 9 were both found at
the C-terminus of HA1 and were mainly loops with a large
solvent-accessible surface area and high hydrophilicity. Site 9 has
also been shown to elicit neutralizing antibody response against
multiple HA subtypes [31].
This work did not identify the receptor binding site separately,
but some of the conserved binding site residues were located
within sites 3, 4 and 5. This lack of specific identification could be
because the receptor binding site is comprised of residues that are
not adjacent in the protein 3-D structure and several of the
residues are not conserved [18].
A broadly cross-reactive antibody response is more probable, if
the nine identified sites have adopted similar conformational
structures in H1, H2 and H5 subtypes, as those in H3 subtype. In
order to test this, we evaluated the structure of identified sites
using the H1 structure (PDB: 1RVZ). We chose H1 structure
alone due to high degree of sequence similarity between H1, H2
and H5 subtypes. In addition to sequence similarity, the nine sites
had a high degree of structure conservation, with similar solvent-
accessible surface and secondary structure (Table 3). Some small
differences in the secondary structure were seen at sites 3, 6, and
7. The hydrophobic/hydrophilic nature of sites also remained
unchanged except for site 9 which had increased hydrophobicity
in the H1 structure. To identify sites that had a high potential of
generating an anti-peptide response, the sites were ranked based
on their solvent accessible surface and hydrophobicity. Hydro-
philic sites were selected and ranked first according to their
solvent accessible surface, followed by the hydrophobic sites
(Table 3).
Five (1, 3, 5, 8, 9) out of the nine identified invariable regions
had a high level of structure conservation between subtypes,
suitable secondary structure and a significantly large solvent-
accessible surface to target an anti-peptide/anti-viral response.
Discussion
The hemagglutinin protein of influenza A virus is the major
surface antigen against which neutralizing antibodies are produced
and, hence, a major constituent of all vaccine formulations.
However, this protein undergoes rapid evolutionary variation that
leads to a change in its antigenic structure, and vaccines have to be
reformulated so as to include the hemagglutinin protein from the
emerging new viral strain. Thus, there is critical need for the
development of an anti-viral measure to protect against any
emerging Influenza A pathogen. One possible solution is an anti-
peptide antibody that is directed against the conserved region of
the hemaggutinin protein that is represented in all the current and
possibly future viral strains. Such an anti-viral response will also
dramatically speed up development of vaccines against new viral
strains until viral-specific reagents are developed.
T-cells, which mediate cellular immune responses, can target
more conserved peptides from internal proteins and have the
potential to provide wider protection. The role of both CD4+ T-
cell and CD8+ T-cell in influenza infection have been extensively
studied [32,33]. CD4+ T-cells and CD8+ T-cells recognize
antigens presented by MHC class II and class I molecules,
respectively. Most of the conserved internal protein sequences
belong to class 1 epitopes and CD8+ response, in particular, is
being considered in novel vaccine therapies [33,34]. However,
unlike antibody response, T-cell response is not sterilizing and
cannot prevent infection of the host cells. Therefore, antibody
based vaccine approaches, although currently strain specific, are
the primary means of resistance and recovery from influenza
infection.
We conducted a comprehensive HA sequence analysis of major
subtypes of Influenza A virus to identify regions that were
conserved between subtypes. A combination of protein sequence
alignment, and the correlation score with the subtype that gave
most significant alignment with other subtypes was used to identify
invariant regions. This method not only gave the most significant
alignment result, but also eliminated differences arising from the
variable number of available sequences of different subtypes and
such an approach can be useful for other viruses with high rates of
mutation.
Computational searches for conserved residues have been
extensively done in case of human immunodeficiency virus
(HIV-1), and these results have indicated that the most highly
variable regions correlate with B-cell epitopes that are res-
ponsible for viral immune escape [35]. Because it is not known
how to induce or modulate the immune responses to target
conserved regions, such studies have not been used for the
development of vaccines/anti-viral agents. An anti-viral therapy
for Influenza A virus that is based on regions that are highly
H2 H1 H3 H5
Column
Number
Consensus
Residue
Column
Number
Consensus
Residue
Column
Number
Consensus
Residue
Column
Number
Consensus
Residue
Residue
Numbering
from 1HGJ
Final
conservation
Score
243 R 246 R 246 R 242 R 220 0.98
244 P 247 P 247 P 243 S 221 0.08
245 (K) 248 (K) 248 (R) 244 (K) 222 (0)
246 V 249 V 249 V 245 V 223 0.95
doi:10.1371/journal.pone.0009268.t001
Table 1. Cont.
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H2 H1 H3 H5
Column
Number
Consensus
Residue
Column
Number
Consensus
Residue
Column
Number
Consensus
Residue
Column
Number
Consensus
Residue
Residue
Numbering
from 1HGJ
Final
conservation
Score
SITE 6
272 G 275 G 275 G 271 G 249 1
273 N 276 N 276 N 272 N 250 1
274 (L) 277 (L) 277 (L) 273 (F) 251 (0)
275 (I) 278 (I) 278 (I) 274 (I) 252 (0.64)
276 A 279 A 279 A 275 A 253 0.99
277 P 280 P 280 P 276 P 254 1
SITE 7
304 K 307 K 306 E 303 K 280 0
305 C 308 C 307 C 304 C 281 0.97
306 Q 309 Q 308 I 305 Q 282 0
307 T 310 T 309 T 306 T 283 1
308 P 311 P 310 P 307 P 284 1
309 L 312 Q 311 N 308 M 285 0
310 G 313 G 312 G 309 G 286 1
311 A 314 A 313 S 310 A 287 0
312 I 315 I 314 I 311 I 288 1
SITE 8
317 P 320 P 319 P 316 P 293 1
318 F 321 F 320 F 317 F 294 0.99
319 H 322 Q 321 Q 318 H 295 0
320 N 323 N 322 N 319 N 296 1
321 (V) 324 (V) 323 (V) 320 (I) 297 (0)
322 H 325 H 324 N 321 H 298 0
323 P 326 P 325 R 322 P 299 0
324 (L) 327 (V) 326 (I) 323 (L) 300 (0)
325 T 328 T 327 T 324 T 301 1
326 I 329 I 328 Y 325 I 302 0
327 G 330 G 329 G 326 G 303 1
328 E 331 E 330 A 327 E 304 0
329 C 332 C 331 C 328 C 305 1
330 P 333 P 332 P 329 P 306 1
331 (K) 334 (K) 333 (R) 330 (K) 307 (0.06)
332 Y 335 Y 334 Y 331 Y 308 1
333 V 336 V 335 V 332 V 309 0.99
334 (K) 337 (R) 336 (K) 333 (K) 310 (0.02)
SITE 9
341 (A) 344 (V) 343 (A) 340 (A) 317 (0.1)
342 T 345 T 344 T 341 T 318 0.98
343 G 346 G 345 G 342 G 319 1
344 (L) 347 (L) 346 (M) 343 (L) 320 (0)
345 R 348 R 347 R 344 R 321 0.99
346 N 349 N 348 N 345 N 322 1
347 V 350 I 349 V 346 S 323 0
348 P 351 P 350 P 347 P 324 1
doi:10.1371/journal.pone.0009268.t002
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Site no. Rank
Total no. of
residues No. of residues and theirsecondary structure SAS (A
2)
SAS per
residue (A
2)
Hydrophobicity
(Total)
a-helical b-structure Turn/coil/loop
16 7 7
(7)
554.40
(571.97)
79.2
(81.71)
5.1
(8.4)
25 8 5
(5)
3
(3)
186.38
(204)
26.6
(25.50)
22.1
(22.4)
34 1 3 5
(5)
26
(8)
545.95
(596.23)
41.99
(45.86)
27.1
(29.5)
48 9 8
(8)
1
(1)
105.47
(105.28)
11.71
(11.69)
2.2
(7)
51 9 9
(9)
554.36
(602.84)
61.59
(66.98)
24.6
(28.1)
69 6 5
(4)
1
(2)
37.20
(31.86)
6.2
(5.31)
4.6
(4.6)
77 9 2
(4)
7
(5)
200.73
(271.43)
22.30
(30.16)
1
(2.5)
83 1 8 6
(6)
12
(12)
972.69
(991.75)
54.04
(55.09)
29.1
(210.7)
92 8 1
(1)
7
(7)
445.79
(524.13)
55.72
(65.53)
22.8
(1.8)
The secondary structure details, solvent accessible surface (SAS) and hydrophobicity value of each identified conserved region is shown. All the values were obtained
from the H3 structure except the values in bracket that were calculated from the H1 structure.
doi:10.1371/journal.pone.0009268.t003
Figure 2. Conserved regions/sites mapped on the HA structure. (A) Position of the conserved regions were depicted on the HA monomer,
shown as a flat ribbon model. The crystal structure of H3 subtype (PDB: 1HGJ) was used to map the identified conserved regions (colored in red). (B)
The conserved regions shown in Figure 2A were enlarged to depict the 3-D structure details.
doi:10.1371/journal.pone.0009268.g002
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significant strategic advantage provided that the above regions
can be selectively targeted. There are many uncertainties when
using whole protein as an antigen, such as localizing the
antibody binding sites, directing the antibody response to
certain sites and defining how amino-acid changes alter
antibody binding in the context of a complex structure. The
generation of anti-peptide antibodies with predefined sequence
specificity is a promising alternative approach provided the
antibodies that recognize and neutralize the native protein can
be generated. It appears by large number of experimental
reports using human immunodeficiency virus HIV-1 that many
such peptides antibodies can recognize and, in some cases,
neutralize some HIV-1 viruses [36,37].
The success of binding of anti-peptide antibodies to native
protein has been attributed to many structural properties and
includes secondary structure, hydrophilicity and surface exposure
of protein binding sites; however, the contribution of any indi-
vidual parameter or a combination that can assure an antigenic
response is currently unknown[22,23,38,39]. Although, this
structural correlation is similar to the antibody response when
the whole protein is the immunogen, the immune response is not
against the complex protein structure and, hence, easier to predict
and control. In this context, peptides spanning the five identified
conserved regions with structural parameters required for an
antibody response can be tested with or without small variations
for a broadly cross-reactive anti-viral response. The conserved
regions adopt similar conformational structures in different
subtypes, further validating the results obtained by sequence
analysis and suggests that they have a potential of protecting
against heterologous viral strains. This in silico approach will also
need validation by experimental methods and in animal models.
This study establishes the identity and structural features of all
conserved regions of hemagglutinin protein of Influenza A viruses.
These regions/sequences can be selected as the first step in the
development of new peptide vaccine strategies, and for the
generation of anti-peptide antibodies as novel anti-virals and cross-
reactive immunological reagents, and may provide a solution for
neutralization of any existing or emerging Influenza A pathogen.
Supporting Information
Table S1 Correlation score of H2 with other subtypes at each
amino acid residue in HA1 domain. The data obtained from
muscle and compass alignments was tabulated. The H3 sequence
(PDB: 1HGJ) was added to follow the H3 numbering. The
consensus residue at each amino acid position, the frequency of
consensus residue, correlation of H2 with other subtypes and the
final conservation score at each amino acid position is shown.
Found at: doi:10.1371/journal.pone.0009268.s001 (0.10 MB
XLS)
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